Showing results (1-10 of 334) with videos related to
Sort By:
Pageof 34
Diabetes|December 1, 1991
Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetesB Ludvik, B Lell, E Hartter, et al.Acta Medica Austriaca|January 1, 1991
[Role of amylin in the pathogenesis of type II diabetes mellitus]R Prager, B Ludvik, E HartterDiabetologia|January 1, 1991
Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humansE Hartter, T Svoboda, B Ludvik, et al.The Clinical Investigator|December 1, 1994
Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term studyM Capek, C Schnack, B Ludvik, et al.Diabetologia|January 1, 1993
Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humansB Ludvik, M Clodi, A Kautzky-Willer, et al.The Journal of Clinical Investigation|November 1, 1994
Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretionB Ludvik, M Clodi, A Kautzky-Willer, et al.Klinische Wochenschrift|January 1, 1986
Thyroid hormones and pericardial effusion may influence plasma levels of atrial natriuretic peptide (ANP) in humansM Weissel, C Punzengruber, E Hartter, et al.Zeitschrift Fur Kardiologie|February 1, 1987
[Peripheral and right atrial plasma levels of atrial natriuretic peptide and their relation to mean atrial pressure]C Punzengruber, E Hartter, M Weissel, et al.Journal of Cardiovascular Pharmacology|January 1, 1991
The effects of ramipril on glucose tolerance, insulin secretion, and insulin sensitivity in patients with hypertensionB Ludvik, E Kueenburg, M Brunnbauer, et al.Wiener Klinische Wochenschrift|January 1, 1994
Apolipoprotein (a) levels in patients with type 1 diabetes mellitus are unrelated to metabolic control or vascular diseaseP Knöbl, P Pietschmann, C Schnack, et al.Pageof 34